Literature DB >> 507095

Echocardiographic assessment of cardiac anatomy and function in acromegalic patients.

D D Savage, W L Henry, R C Eastman, J S Borer, P Gorden.   

Abstract

Echocardiography was used to evaluate cardiac anatomy and function in 25 patients with accromegaly. Eighty per cent of the patients (20 of 25) had abnormal echocardiograms including 13 patients without other signs or symptoms of cardiac involvement. The most common abnormality was increased left ventricular mass with concentric left ventricular wall thickening, which was found in 64 per cent (16 of 25) of the patients. Increased left ventricular transverse dimension at end diastole was found in 36 per cent (nine of 25) of the patients. Other echocardiographic abnormalities found included left atrial or aortic root enlargement (three patients), disproportionate septal thickening (one patient) and depressed left ventricular ejection fraction (three patients). Since five of the patients with increased left ventricular mass had no history of hypertension or hyperthyroidism, the increased mass cannot be ascribed solely to these conditions commonly associated with acromegaly. Furthermore, the degree of cardiac hypertrophy showed no significant correlation with pre- or post-treatment growth hormone levels, or with known duration of acromegaly prior to treatment. Thus, although the pathophysiology and significance of cardiac abnormalities in acromegalic patients is not yeat fully understood, echocardiography does provide a sensitive tool for detecting such abnormalities before they are otherwise apparent.

Entities:  

Mesh:

Year:  1979        PMID: 507095     DOI: 10.1016/0002-9343(79)90742-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

1.  Doppler echocardiographic patterns in patients with acromegaly.

Authors:  M Terzolo; L Avonto; C Matrella; R Pozzi; S Luceri; G Borretta; F Pecchio; G Ugliengo; G P Magro; G Reimondo
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

2.  Acromegalic cardiomyopathy. An echocardiographic study.

Authors:  L Lusiani; G Ronsisvalle; A Visonà; V Castellani; A Bonanome; A Pagnan; F Facchin; N Sicolo; G Federspil
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

3.  Cardiac function in endocrine diseases: I. Acromegaly.

Authors:  R Griebenow; L Krämer; U Frangenberg; B Allolio; D Kaulen; F Saborowski; W Winkelmann
Journal:  Klin Wochenschr       Date:  1989-11-17

Review 4.  Role of growth hormone in chronic heart failure. Therapeutic implications.

Authors:  M Volterrani; F Manelli; M Cicoira; R Lorusso; A Giustina
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

5.  The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly.

Authors:  Laura De Marinis; Antonio Bianchi; Gherardo Mazziotti; Marco Mettimano; Domenico Milardi; Alessandra Fusco; Vincenzo Cimino; Giulio Maira; Alfredo Pontecorvi; Andrea Giustina
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 6.  The role of combination medical therapy in the treatment of acromegaly.

Authors:  Dawn Shao Ting Lim; Maria Fleseriu
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

7.  Acromegalic cardiopathy: a left ventricular scintigraphic study.

Authors:  N Sicolo; F Bui; M Sicolo; L Varotto; C Martini; C Macor; G Federspil
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

8.  Cardiovascular effects of high-dose growth hormone treatment in growth hormone-deficient children.

Authors:  R Crepaz; W Pitscheider; G Radetti; C Paganini; L Gentili; G Morini; E Braito; G Mengarda
Journal:  Pediatr Cardiol       Date:  1995 Sep-Oct       Impact factor: 1.655

9.  Relation of endocrine and cardiac findings in acromegalics.

Authors:  G Kahaly; C Stover; J Beyer; S Mohr-Kahaly
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

10.  Cardiac effects of growth hormone in short normal children: results after four years of treatment.

Authors:  P E Daubeney; E S McCaughey; C Chase; J M Walker; Z Slavik; P R Betts; S A Webber
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.